Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers in Patients With Extensive-Stage Small Cell Lung Carcinoma Treated with Atezolizumab in Combination with Chemotherapy: Single Center Experience
2017 ◽
2020 ◽
Vol 28
(1)
◽
pp. 143-150
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):